ZA982912B - 6,7-disubstituted-4-aminopyrido [2,3-d] pyrimidine compounds - Google Patents

6,7-disubstituted-4-aminopyrido [2,3-d] pyrimidine compounds

Info

Publication number
ZA982912B
ZA982912B ZA982912A ZA982912A ZA982912B ZA 982912 B ZA982912 B ZA 982912B ZA 982912 A ZA982912 A ZA 982912A ZA 982912 A ZA982912 A ZA 982912A ZA 982912 B ZA982912 B ZA 982912B
Authority
ZA
South Africa
Prior art keywords
aminopyrido
disubstituted
pyrimidine compounds
pyrimidine
compounds
Prior art date
Application number
ZA982912A
Other languages
English (en)
Inventor
Shripad S Bhagwat
Chih-Hung Lee
Richard J Perner
Yu-Gui Gu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA982912B publication Critical patent/ZA982912B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA982912A 1997-04-16 1998-04-06 6,7-disubstituted-4-aminopyrido [2,3-d] pyrimidine compounds ZA982912B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83439397A 1997-04-16 1997-04-16

Publications (1)

Publication Number Publication Date
ZA982912B true ZA982912B (en) 1998-10-09

Family

ID=25266829

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982912A ZA982912B (en) 1997-04-16 1998-04-06 6,7-disubstituted-4-aminopyrido [2,3-d] pyrimidine compounds

Country Status (20)

Country Link
EP (1) EP0979230A1 (no)
JP (1) JP2001520649A (no)
KR (1) KR20010006453A (no)
CN (1) CN1259948A (no)
AR (1) AR012435A1 (no)
AU (1) AU744528B2 (no)
BG (1) BG103861A (no)
BR (1) BR9809088A (no)
CA (1) CA2287465A1 (no)
CO (1) CO4940439A1 (no)
HU (1) HUP0001402A3 (no)
IL (1) IL131892A0 (no)
NO (1) NO995033L (no)
NZ (1) NZ337844A (no)
PL (1) PL336262A1 (no)
SK (1) SK142099A3 (no)
TR (1) TR199902456T2 (no)
TW (1) TW458977B (no)
WO (1) WO1998046603A1 (no)
ZA (1) ZA982912B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
ATE305303T1 (de) * 2001-02-12 2005-10-15 Hoffmann La Roche 6-substituierte pyridopyrimidine
CN101356179A (zh) 2004-11-12 2009-01-28 塔夫茨大学信托人 脂肪酶抑制剂
WO2008121257A1 (en) * 2007-03-28 2008-10-09 Merck & Co., Inc. Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
US9145433B2 (en) * 2012-10-05 2015-09-29 Rigel Pharmaceuticals, Inc. GDF-8 inhibitors
WO2017205848A1 (en) * 2016-05-27 2017-11-30 Legacy Emanuel Hospital & Health Center Methanocarba derivatives of pseudoribose that inhibit adenosine kinase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
CO4940439A1 (es) 2000-07-24
HUP0001402A3 (en) 2001-01-29
SK142099A3 (en) 2000-05-16
CN1259948A (zh) 2000-07-12
NO995033D0 (no) 1999-10-15
AU744528B2 (en) 2002-02-28
TW458977B (en) 2001-10-11
EP0979230A1 (en) 2000-02-16
HUP0001402A2 (hu) 2000-10-28
CA2287465A1 (en) 1998-10-22
NZ337844A (en) 2001-11-30
AU7098198A (en) 1998-11-11
KR20010006453A (ko) 2001-01-26
AR012435A1 (es) 2000-10-18
BR9809088A (pt) 2000-08-01
WO1998046603A1 (en) 1998-10-22
TR199902456T2 (xx) 2000-07-21
IL131892A0 (en) 2001-03-19
BG103861A (en) 2000-06-30
JP2001520649A (ja) 2001-10-30
NO995033L (no) 1999-12-15
PL336262A1 (en) 2000-06-19

Similar Documents

Publication Publication Date Title
PL345118A1 (en) Pyrrolo[2,3-d]pyrimidine compounds
HUP0102574A3 (en) Pyrrolo[2,3-d]pyrimidine compounds
EG24399A (en) Pyrrolo[2,3-D]pyrimidine compounds
ZA986250B (en) 5H-thiazolo[3,2-A]pyrimidine derivatives
HK1069577A1 (en) Pyrazolo [4,3-D] pyrimidine derivatives
AU1794697A (en) 7-alkyl-pyrrolo{2,3-d}pyrimidines
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
ZA983177B (en) 5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
GB9506309D0 (en) Pyrimidine compounds
IL136500A0 (en) 1,4-diazacycloheptane derivatives
ZA982912B (en) 6,7-disubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
PL336265A1 (en) 5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
EP0904271A4 (en) 5,6,7,8-tetrahydropyrido [2,3-d] PYRIMIDINE
ZA994004B (en) Pyrrolo[2,3-d]pyrimidine compounds.
SI1087970T1 (en) PYRROLO 2,3-d)PYRIMIDINE COMPOUNDS
GB2316077B (en) Pyrimidine Compounds
AU3500997A (en) 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidine derivatives
SI1210349T1 (en) PYRAZOLO 4,3-d)PYRIMIDINES
EP0954316A4 (en) PYRIMIDINE DERIVATIVES